| Financial Year |
March 31 2023 |
| Monetary Funds |
664,540,083.81 |
| Held-for-trading Financial Assets |
604,391,103.88 |
| Notes Receivable |
166,422,998.12 |
| Accounts Receivable |
1,230,484,048.39 |
| Advances to Suppliers |
151,207,695.85 |
| Other Receivables |
38,525,487.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
920,967,324.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
924,292,634.69 |
| Total Current Assets |
5,086,907,388.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
890,946,002.58 |
| Under-construction Projects |
56,549,482.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,967,180.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
59,206,092.03 |
| Other Non-Current Assets |
159,594,722.63 |
| Sub-Total of Non-Current Assets |
1,328,554,871.75 |
| Total Assets |
6,415,462,260.35 |
| Short-Term Loans |
410,286,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,020,176,818.76 |
| Accounts Payable |
488,779,393.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,460,676.06 |
| Taxes Payable |
1,798,487.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,913,471.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,971,567.40 |
| Other Current Liabilities |
108,214,919.94 |
| Sub-Total of Current Liabilities |
2,085,443,077.34 |
| Long-term Loans |
50,045,069.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
87,350,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
71,234,758.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
324,590,542.96 |
| Total Liabilities |
2,410,033,620.30 |
| Paid-In Capital(Or Share Stock) |
121,170,892.00 |
| Capital Surplus |
2,510,327,980.11 |
| Surplus Reserve |
83,146,473.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,290,782,135.57 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,005,428,640.05 |
| Owner's Equity（Stockholder's Equity） |
4,005,428,640.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,415,462,260.35 |
